Dysregulation of Ceruloplasmin, α2‐Macroglobulin, and Alpha‐2‐HS‐Glycoprotein in Transfusion‐Dependent Thalassemia

Sumera, Afshan orcid iconORCID: 0000-0002-4108-2271, Radhakrishnan, Ammu K., Cheong, Soon Keng, Baba, Abdul Aziz and Sen, Kalyani (2025) Dysregulation of Ceruloplasmin, α2‐Macroglobulin, and Alpha‐2‐HS‐Glycoprotein in Transfusion‐Dependent Thalassemia. Advances in Hematology, 2025 (1). ISSN 1687-9104

[thumbnail of VOR]
Preview
PDF (VOR) - Published Version
Available under License Creative Commons Attribution.

502kB

Official URL: https://doi.org/10.1155/ah%2F2179600

Abstract

Transfusion-dependent thalassemia (TDT) is a severe inherited anemia characterized by impaired synthesis of hemoglobin chains. Disease progression and TDT severity are potentially linked to oxidative stress and protein damage. This study aimed to explore the expression patterns of ceruloplasmin (CP), α2-macroglobulin (A2M), and alpha-2-HS-glycoprotein (AHSG) in TDT serum through quantitative proteomic profiling. The results were validated using enzyme-linked immunosorbent assays (ELISA). The study participants were divided into three groups based on the duration of blood transfusion. Age and gender-matched normal individuals served as controls. The results revealed the downregulation of these proteins. The reduced levels of these proteins may contribute to tissue damage in TDT patients, primarily due to increased oxidative stress. For example, decreased CP levels can disrupt iron and copper metabolism, leading to heightened oxidative stress and rendering red blood cell membranes more susceptible to rupture due to active oxygen radicals. In summary, CP, A2M, and AHSG association with iron metabolism, inflammation, and oxidative stress underscores their potential relevance in understanding TDT’s pathogenesis and progression. These findings may pave the way for improved diagnostic and therapeutic strategies for TDT patients.


Repository Staff Only: item control page